PPC
KRTX

Park Place Capital’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Park Place Capital’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4
Closed -$1.27K – 927
2023
Q4 		$1.27K Hold
4
– – ﹤0.01% 823
2023
Q3 		$676 Hold
4
– – ﹤0.01% 994
2023
Q2 		$867 Hold
4
– – ﹤0.01% 989
2023
Q1 		$727 Hold
4
– – ﹤0.01% 997
2022
Q4 		$1K Buy
+4
New +$858 ﹤0.01% 1026

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Park Place Capital's KRTX Position: Q1 2024 in Review

Park Place Capital sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 4 shares — an estimated $1.27K sold.

Park Place Capital first reported a position in KRTX in Q4 2022 and held it in 5 quarters. The position peaked at $1.27K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Park Place Capital reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Park Place Capital sold 4 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.27K.
  • Park Place Capital first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2022 and held it in 5 quarters.
  • Park Place Capital's Karuna Therapeutics, Inc. Common Stock position peaked at $1.27K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Park Place Capital's 13F filing for Q1 2024, filed 18 Apr 2024.